<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03539107</url>
  </required_header>
  <id_info>
    <org_study_id>Popiel02</org_study_id>
    <nct_id>NCT03539107</nct_id>
  </id_info>
  <brief_title>Voiding Assessment Based on Minimum Spontaneous Void of 150 mL Compared to Retrograde Fill Method After Female Pelvic Floor Reconstructive Surgery</brief_title>
  <official_title>Voiding Assessment Based on Minimum Spontaneous Void of 150 mL Compared to Retrograde Fill Method After Female Pelvic Floor Reconstructive Surgery: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare voiding assessment based on a minimum spontaneous voided volume of
      150 cc with the standard retrograde fill approach in women after pelvic floor procedures.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Failure rate</measure>
    <time_frame>Up to 2 days post op</time_frame>
    <description>The percentage of subjects who did not meet the required voiding assessment criteria and needed catheterization .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>False pass rate</measure>
    <time_frame>up to 30 days after discharge.</time_frame>
    <description>The percentage of women who initially met the voiding assessment but returned for re-catheterization due to voiding difficulty .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Force of stream (FOS)</measure>
    <time_frame>Up to 2 days post op.</time_frame>
    <description>Patient reported force of stream (FOS) during voiding; (0 being no urination, 10 being normal strong flow).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Force of stream (FOS)</measure>
    <time_frame>Up to 2 days post-surgery.</time_frame>
    <description>Patient reported force of stream (FOS) during voiding; (0 being no urination, 10 being normal strong flow).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Questionnaire for Voiding Assessment-method used</measure>
    <time_frame>Up to 2 days post-surgery.</time_frame>
    <description>This question asks &quot;How satisfied were you with the method we used to evaluate how well you could urinate after our surgery?&quot; It is measured on a continuum from 0 (very dissatisfied) to 100 (very satisfied).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Questionnaire for Voiding Assessment-negative emotions</measure>
    <time_frame>Up to 2 days post-surgery.</time_frame>
    <description>This question asks &quot;Did you experience any negative emotions such as fear or anxiety when we were evaluating urination after our surgery?&quot; It is measured on a continuum from 0 (many negative emotions) to 100 (no negative emotions).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Questionnaire for Voiding Assessment-recommend method</measure>
    <time_frame>Up to 2 days post-surgery.</time_frame>
    <description>This question asks &quot;How likely would you be to recommend to a friend or family member, the method we used to evaluate your urination after our surgery, if they were in the same situation?&quot; It is measured on a continuum from 0 (very unlikely) to 100 (very likely).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Questionnaire for Voiding Assessment-convenience of method</measure>
    <time_frame>Up to 2 days post-surgery.</time_frame>
    <description>This question asks &quot;How convenient was the method we used to evaluate your urination after our surgery (e.g. time, ease etc.)? It is measured on a continuum from 0 (very inconvenient) to 100 (very convenient).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Questionnaire for Voiding Assessment-preferred method</measure>
    <time_frame>Up to 2 days post-surgery.</time_frame>
    <description>This question asks the patient: &quot;If it was all up to you, which It is measured on a continuum from 0 (strongly prefer backfill before catheter) to 100 (strongly prefer no backfill before catheter removal).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score</measure>
    <time_frame>One day post-surgery.</time_frame>
    <description>This outcome is measured by a 10-point visual analog scale where 0= no pain, 10=worst pain you have ever experienced.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary tract infection (UTI)</measure>
    <time_frame>Up to 30 days post surgery.</time_frame>
    <description>UTI is defined as culture-proven bladder infection or, in the absence of a culture, clinical suspicion of a bladder infection that resulted in treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative complications</measure>
    <time_frame>Up to 30 days post-surgery.</time_frame>
    <description>Post-operative complications assessed by medical record review.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Up to 2 days post-surgery.</time_frame>
    <description>Length of hospital stay assessed by medical record review.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Urinary Incontinence</condition>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Spontaneous void</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will not have retrograde fill of bladder, rather will be required to void 150 mL spontaneously prior to discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Retrograde bladder fill</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will have their bladder retrograde filled with 300mL of fluid prior to a voiding trial.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Retrograde bladder fill</intervention_name>
    <description>Subjects will have their bladder retrograde filled with 300mL of fluid prior to a voiding trial.</description>
    <arm_group_label>Retrograde bladder fill</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>spontaneous void</intervention_name>
    <description>Subjects will not have retrograde fill of bladder, rather will be required to void 150 mL spontaneously prior to discharge.</description>
    <arm_group_label>Spontaneous void</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All 18-year-old or older women who undergo surgery for urinary incontinence and/or
             pelvic organ prolapse (POP)

        Exclusion Criteria:

          -  Patients who require prolonged Foley catheter or suprapubic catheter
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harmanli Oz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oz Harmanli, MD</last_name>
    <phone>203-785-6927</phone>
    <email>oz.harmanli@yale.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patrick M. Popiel, MD</last_name>
    <phone>203-785-6927</phone>
    <email>patrick.popiel@yale.edu</email>
  </overall_contact_backup>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2018</study_first_submitted>
  <study_first_submitted_qc>May 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2018</study_first_posted>
  <last_update_submitted>May 24, 2018</last_update_submitted>
  <last_update_submitted_qc>May 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

